Literature DB >> 33386018

Evaluation of the precision of operative augmented reality compared to standard neuronavigation using a 3D-printed skull.

Julien Haemmerli1, Alioucha Davidovic2, Torstein R Meling1, Lara Chavaz2, Karl Schaller1, Philippe Bijlenga1.   

Abstract

OBJECTIVE: Augmented reality (AR) in cranial surgery allows direct projection of preregistered overlaid images in real time on the microscope surgical field. In this study, the authors aimed to compare the precision of AR-assisted navigation and standard pointer-based neuronavigation (NV) by using a 3D-printed skull in surgical conditions.
METHODS: A commercial standardized 3D-printed skull was scanned, fused, and referenced with an MR image and a CT scan of a patient with a 2 × 2-mm right frontal sinus defect. The defect was identified, registered, and integrated into NV. The target was physically marked on the 3D-printed skull replicating the right frontal sinus defect. Twenty-six subjects participated, 25 of whom had no prior NV or AR experience and 1 with little AR experience. The subjects were briefly trained in how to use NV, AR, and AR recalibration tools. Participants were asked to do the following: 1) "target the center of the defect in the 3D-printed skull with a navigation pointer, assisted only by NV orientation," and 2) "use the surgical microscope and AR to focus on the center of the projected object" under conventional surgical conditions. For the AR task, the number of recalibrations was recorded. Confidence regarding NV and AR precision were assessed prior to and after the experiment by using a 9-level Likert scale.
RESULTS: The median distance to target was statistically lower for AR than for NV (1 mm [Q1: 1 mm, Q3: 2 mm] vs 3 mm [Q1: 2 mm, Q3: 4 mm] [p < 0.001]). In the AR task, the median number of recalibrations was 4 (Q1: 4, Q3: 4.75). The number of recalibrations was significantly correlated with the precision (Spearman rho: -0.71, p < 0.05). The trust assessment after performing the experiment scored a median of 8 for AR and 5.5 for NV (p < 0.01).
CONCLUSIONS: This study shows for the first time the superiority of AR over NV in terms of precision. AR is easy to use. The number of recalibrations performed using reference structures increases the precision of the navigation. The confidence regarding precision increases with experience.

Entities:  

Keywords:  augmented reality; neuronavigation; precision; recalibration

Year:  2021        PMID: 33386018     DOI: 10.3171/2020.10.FOCUS20789

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  4 in total

Review 1.  Intraoperative MRI versus intraoperative ultrasound in pediatric brain tumor surgery: is expensive better than cheap? A review of the literature.

Authors:  Carlo Giussani; Andrea Trezza; Vittorio Ricciuti; Andrea Di Cristofori; Andrea Held; Valeria Isella; Maura Massimino
Journal:  Childs Nerv Syst       Date:  2022-05-05       Impact factor: 1.532

2.  Evaluation of the precision of navigation-assisted endoscopy according to the navigation tool setup and the type of endoscopes.

Authors:  Lara Chavaz; Alioucha Davidovic; Torstein R Meling; Shahan Momjian; Karl Schaller; Philippe Bijlenga; Julien Haemmerli
Journal:  Acta Neurochir (Wien)       Date:  2022-06-28       Impact factor: 2.816

Review 3.  Visualization, navigation, augmentation. The ever-changing perspective of the neurosurgeon.

Authors:  A Boaro; F Moscolo; A Feletti; G M V Polizzi; S Nunes; F Siddi; M L D Broekman; F Sala
Journal:  Brain Spine       Date:  2022-08-17

Review 4.  The Role of 3D Printing in Planning Complex Medical Procedures and Training of Medical Professionals-Cross-Sectional Multispecialty Review.

Authors:  Jarosław Meyer-Szary; Marlon Souza Luis; Szymon Mikulski; Agastya Patel; Finn Schulz; Dmitry Tretiakow; Justyna Fercho; Kinga Jaguszewska; Mikołaj Frankiewicz; Ewa Pawłowska; Radosław Targoński; Łukasz Szarpak; Katarzyna Dądela; Robert Sabiniewicz; Joanna Kwiatkowska
Journal:  Int J Environ Res Public Health       Date:  2022-03-11       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.